Risk of myocardial infarction in patients with atrial fibrillation using vitamin K antagonists, aspirin or direct acting oral anticoagulants

Leo M. Stolk*, Frank de Vries, Chiel Ebbelaar, Anthonius de Boer, Tom Schalekamp, Patrick Souverein, Arina ten Cate-Hoek, Andrea M. Burden

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1835-1843
Number of pages9
JournalBritish Journal of Clinical Pharmacology
Volume83
Issue number8
DOIs
Publication statusPublished - Aug 2017

Keywords

  • anticoagulants
  • cardiovascular pharmacology
  • pharmacoepidemiology
  • RANDOMIZED-CONTROLLED-TRIALS
  • INTERVENTIONAL TRIALS
  • NATIONWIDE COHORT
  • WARFARIN
  • DABIGATRAN
  • METAANALYSIS
  • SAFETY
  • EFFICACY
  • STROKE
  • ASSOCIATION

Cite this

Stolk, Leo M. ; de Vries, Frank ; Ebbelaar, Chiel ; de Boer, Anthonius ; Schalekamp, Tom ; Souverein, Patrick ; ten Cate-Hoek, Arina ; Burden, Andrea M. / Risk of myocardial infarction in patients with atrial fibrillation using vitamin K antagonists, aspirin or direct acting oral anticoagulants. In: British Journal of Clinical Pharmacology. 2017 ; Vol. 83, No. 8. pp. 1835-1843.
@article{90f7f3aad4a742af919cce701f4e5c64,
title = "Risk of myocardial infarction in patients with atrial fibrillation using vitamin K antagonists, aspirin or direct acting oral anticoagulants",
keywords = "anticoagulants, cardiovascular pharmacology, pharmacoepidemiology, RANDOMIZED-CONTROLLED-TRIALS, INTERVENTIONAL TRIALS, NATIONWIDE COHORT, WARFARIN, DABIGATRAN, METAANALYSIS, SAFETY, EFFICACY, STROKE, ASSOCIATION",
author = "Stolk, {Leo M.} and {de Vries}, Frank and Chiel Ebbelaar and {de Boer}, Anthonius and Tom Schalekamp and Patrick Souverein and {ten Cate-Hoek}, Arina and Burden, {Andrea M.}",
year = "2017",
month = "8",
doi = "10.1111/bcp.13264",
language = "English",
volume = "83",
pages = "1835--1843",
journal = "British Journal of Clinical Pharmacology",
issn = "0306-5251",
publisher = "Wiley",
number = "8",

}

Risk of myocardial infarction in patients with atrial fibrillation using vitamin K antagonists, aspirin or direct acting oral anticoagulants. / Stolk, Leo M.; de Vries, Frank; Ebbelaar, Chiel; de Boer, Anthonius; Schalekamp, Tom; Souverein, Patrick; ten Cate-Hoek, Arina; Burden, Andrea M.

In: British Journal of Clinical Pharmacology, Vol. 83, No. 8, 08.2017, p. 1835-1843.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Risk of myocardial infarction in patients with atrial fibrillation using vitamin K antagonists, aspirin or direct acting oral anticoagulants

AU - Stolk, Leo M.

AU - de Vries, Frank

AU - Ebbelaar, Chiel

AU - de Boer, Anthonius

AU - Schalekamp, Tom

AU - Souverein, Patrick

AU - ten Cate-Hoek, Arina

AU - Burden, Andrea M.

PY - 2017/8

Y1 - 2017/8

KW - anticoagulants

KW - cardiovascular pharmacology

KW - pharmacoepidemiology

KW - RANDOMIZED-CONTROLLED-TRIALS

KW - INTERVENTIONAL TRIALS

KW - NATIONWIDE COHORT

KW - WARFARIN

KW - DABIGATRAN

KW - METAANALYSIS

KW - SAFETY

KW - EFFICACY

KW - STROKE

KW - ASSOCIATION

U2 - 10.1111/bcp.13264

DO - 10.1111/bcp.13264

M3 - Article

VL - 83

SP - 1835

EP - 1843

JO - British Journal of Clinical Pharmacology

JF - British Journal of Clinical Pharmacology

SN - 0306-5251

IS - 8

ER -